Reimagining R&D Portfolio Management
Pharma companies spend years and billions of dollars in clinical development process and trails for new drugs. R&D departments also have to live with uncertainty with several projects running in paral-lel-often sharing facilities or resources between them. Timely completion of these projects is crucial to the commercialization strategies and pipeline assets’ success in order to infuse growth impetus to the long drawn drug development process. Leni – LTI’s AI-based Virtual R&D Portfolio Manager is designed to infuse cognitive insights on the fly into the R&D function helping pharma portfolio managers assess risk of ongoing clinical trial portfolios, simulate and determine success of future clinical trials and studies and predict the success rates of trials as per schedule. All these insights are available in a matter of seconds and in an easy to digest narrative format, which aids in faster decision making and efficient allocation of resources. With Leni’s R&D Portfolio Manager
Reach us
Ask Leni to
- Understand the portfolio performance and associated risks with easy to grasp narratives
- Compare against industry benchmarks to analyze and update resource allocation for projects in pipe-line
- Simulate and predict future performance and risks of existing trials, based on actual performance powered by Monte Carlo simulation algorithms
- Activate your R&D function with the true power of artificial intelligence and machine learning at your finger-tips.
